Dr Annette Lim
allocation, assist with disease surveillance – prediction of malignant transformation and improve surveillance after treatment, reduce the need for invasive procedures during post-treatment surveillance and facilitate early intervention when disease recurrence is suspected and apply the findings and benefits (potentially) more widely to other forms of cancers. Dean of the Royal Australian College of Physicians Professor Richard Doherty says he is delighted to see the RACP GSK Research Establishment Fellowship in Oncology being put to such a valuable project. “I commend GSK on their investment in medical science and innovation. This is an important relationship and the College and all of the recipients certainly value the support. It shows how partnerships between industry and the College can be the catalyst for important projects that drive patient-focused innovations,” said Professor Doherty.
The project is being co-ordinated by Dr Lim, who is a Consultant Medical Oncologist at Sir Charles Gairdner Hospital in Perth and an Adjunct Clinical Senior Lecturer at the University of Western Australia. The translational research involves the collaborative input of the clinical multidisciplinary team and scientists from the university. Dr Annette Lim is the recipient of the RACP GlaxoSmithKline Research Establishment Fellowship in Oncology for 2016. Dr Lim will be using the Award to research: Mechanisms that facilitate metastatic potential in base of tongue carcinomas. The core funding for Dr Lim’s broader project (looking at head and neck cancers more broadly) comes from Garnett Passe & Rodney Williams Memorial Foundation Conjoint Grant, Cancer Council Western Australia Early Career Investigator award and the WA Health/Raine Foundation Clinician Research Fellowship. For more information about GSK visit www.au.gsk.com
Medical Director at GSK Dr Andrew Weekes said “It is a great source of pride for the GSK team to be able to support research which advances understanding in oncology. You just never know where projects like Dr Lim’s might lead. From first principles, there is potential for meaningful impact in the clinical setting, both in diagnosis and in patient care.”
INSPIRE
|
Winter 2016
45